VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 162 filers reported holding VIR BIOTECHNOLOGY INC in Q1 2021. The put-call ratio across all filers is 1.04 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $290,000 | -24.3% | 15,043 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $383,000 | -86.8% | 15,043 | -86.6% | 0.00% | -90.0% |
| Q1 2022 | $2,898,000 | -16.0% | 112,659 | +36.6% | 0.01% | -16.7% |
| Q4 2021 | $3,452,000 | -25.2% | 82,450 | -22.2% | 0.01% | -25.0% |
| Q3 2021 | $4,615,000 | -48.0% | 106,043 | -38.7% | 0.02% | -44.8% |
| Q1 2021 | $8,875,000 | +81.4% | 173,110 | -5.3% | 0.03% | +61.1% |
| Q4 2020 | $4,893,000 | – | 182,712 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $14,609,161 | 17.42% |
| SB INVESTMENT ADVISERS (UK) LTD | 16,684,041 | $156,329,464 | 1.29% |
| Octagon Capital Advisors LP | 325,050 | $3,045,719 | 0.47% |
| SECTOR GAMMA AS | 148,538 | $1,391,801 | 0.36% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 1,345,635 | $12,608,600 | 0.31% |
| ALGERT GLOBAL LLC | 449,685 | $4,214 | 0.20% |
| Quantamental Technologies LLC | 18,519 | $173,523 | 0.16% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 47,000 | $439,920 | 0.15% |
| DUALITY ADVISERS, LP | 123,871 | $1,160,671 | 0.14% |
| Empowered Funds, LLC | 385,135 | $3,608,715 | 0.11% |